Antipsychotic Drug Monitoring

It’s time for rapid and accurate results.

Click here to learn more about our full therapeutic drug monitoring, testing and detection menu.
Want more information about our antipsychotic drug monitoring offerings? Complete the form below and a sales representative will be in touch.
* Required Fields

"Lack of adherence among patients with schizophrenia is associated with increased rates of hospitalization. Identifying problems in adherence prior to symptomatic worsening can lead to fewer hospitalizations and improve clinical outcomes. Therapeutic drug monitoring can improve patient outcomes by avoiding unnecessary dose escalations, reducing adverse drug reactions and facilitating the switch to alternative therapies when appropriate. All of these potential benefits ultimately improve patient outcomes and lead to more cost-effective care."

Dr. Arindam Ghosh, MBBS, PhD
Director of Medical and Scientific Affairs
Beckman Coulter Diagnostics